{
 "drug": "Midazolam Hydrochloride Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "04/02/2020",
 "dayN": 2336,
 "cat": "Anesthesia",
 "companies": [
  "Hospira, Inc., a Pfizer Company",
  "Avet Pharmaceuticals, Inc.",
  "Fresenius Kabi USA, LLC",
  "WG Critical Care",
  "Hikma Pharmaceuticals USA, Inc.",
  "Gland Pharma Limited"
 ],
 "reasons": [
  "Demand increase for the drug",
  "Other",
  "Delay in shipping of the drug"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "0409-2596-03",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA075293"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-2596",
     "0409-2587"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "311700",
     "311702"
    ],
    "spl_id": [
     "6c075a2d-b68b-41a7-aa0c-bcf9894e3f76"
    ],
    "spl_set_id": [
     "affecd4d-1f78-4bbe-5a8d-86849bbdc520"
    ],
    "package_ndc": [
     "0409-2587-04",
     "0409-2587-05",
     "0409-2596-13",
     "0409-2596-03",
     "0409-2596-15",
     "0409-2596-05"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "23155-600-41",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "855-228-9470",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: 8/25/2026",
   "openfda": {
    "application_number": [
     "ANDA090696"
    ],
    "brand_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "generic_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."
    ],
    "product_ndc": [
     "23155-600"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "1666798"
    ],
    "spl_id": [
     "4962482c-a9a7-4aa2-9663-da251cd150dc"
    ],
    "spl_set_id": [
     "8b690f5c-2923-4c34-a8f7-11af5f546b62"
    ],
    "package_ndc": [
     "23155-600-31",
     "23155-600-41"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 23155-600-41)",
   "company_name": "Avet Pharmaceuticals, Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "63323-411-25",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "ANDA075154"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-411",
     "63323-412"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "311700",
     "311702"
    ],
    "spl_id": [
     "9814447b-a93e-42ad-b57e-5db0a5b7f552"
    ],
    "spl_set_id": [
     "a91ce254-14a3-4cbf-8ab8-5da252aa3fdc"
    ],
    "package_ndc": [
     "63323-411-22",
     "63323-411-27",
     "63323-411-15",
     "63323-411-12",
     "63323-411-18",
     "63323-411-25",
     "63323-411-13",
     "63323-411-10",
     "63323-412-18",
     "63323-412-25",
     "63323-412-03",
     "63323-412-02",
     "63323-412-06",
     "63323-412-05",
     "63323-412-13",
     "63323-412-10"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25)",
   "company_name": "Fresenius Kabi USA, LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "63323-412-02",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "ANDA075154"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-412",
     "63323-411"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "311700",
     "311702"
    ],
    "spl_id": [
     "9814447b-a93e-42ad-b57e-5db0a5b7f552"
    ],
    "spl_set_id": [
     "a91ce254-14a3-4cbf-8ab8-5da252aa3fdc"
    ],
    "package_ndc": [
     "63323-411-22",
     "63323-411-27",
     "63323-411-15",
     "63323-411-12",
     "63323-411-18",
     "63323-411-25",
     "63323-411-13",
     "63323-411-10",
     "63323-412-18",
     "63323-412-25",
     "63323-412-03",
     "63323-412-02",
     "63323-412-06",
     "63323-412-05",
     "63323-412-13",
     "63323-412-10"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "44567-611-10",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "888-493-0861",
   "availability": "Available",
   "related_info": "Please check wholesalers and distributors for inventory.",
   "openfda": {
    "application_number": [
     "NDA211844"
    ],
    "brand_name": [
     "MIDAZOLAM IN SODIUM CHLORIDE"
    ],
    "generic_name": [
     "MIDAZOLAM"
    ],
    "manufacturer_name": [
     "WG Critical Care, LLC."
    ],
    "product_ndc": [
     "44567-611",
     "44567-610"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM"
    ],
    "rxcui": [
     "2541170",
     "2541171"
    ],
    "spl_id": [
     "6cea9d5b-d0a6-4f93-b45e-2d615f6c4337"
    ],
    "spl_set_id": [
     "f051776f-94c5-4e34-80ed-f45b9c36881e"
    ],
    "package_ndc": [
     "44567-610-01",
     "44567-610-10",
     "44567-611-01",
     "44567-611-10"
    ],
    "nui": [
     "N0000175694",
     "M0002356"
    ],
    "pharm_class_epc": [
     "Benzodiazepine [EPC]"
    ],
    "pharm_class_cs": [
     "Benzodiazepines [CS]"
    ],
    "unii": [
     "R60L0SM5BC"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10)",
   "company_name": "WG Critical Care",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "76045-211-20",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA203460"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "76045-211",
     "76045-001",
     "76045-002",
     "76045-003"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "998211",
     "1551393",
     "1551395"
    ],
    "spl_id": [
     "ec9c9aee-b95f-4645-bf17-df7f1e3967d3"
    ],
    "spl_set_id": [
     "1cc9ba6e-fa1b-405e-9de8-720c567b2a73"
    ],
    "package_ndc": [
     "76045-211-00",
     "76045-211-20",
     "76045-001-00",
     "76045-001-20",
     "76045-002-00",
     "76045-002-10",
     "76045-003-00",
     "76045-003-20"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20)",
   "company_name": "Fresenius Kabi USA, LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "0641-6056-10",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA075243"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6056",
     "0641-6057",
     "0641-6059",
     "0641-6061",
     "0641-6063",
     "0641-6060"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "311700",
     "311702"
    ],
    "spl_id": [
     "559c03fb-24ea-4b7b-8afd-e33cb3a2340a"
    ],
    "spl_set_id": [
     "575d8bf0-7af7-427c-a231-966e2a5e070d"
    ],
    "package_ndc": [
     "0641-6057-01",
     "0641-6057-10",
     "0641-6057-25",
     "0641-6059-01",
     "0641-6059-10",
     "0641-6056-01",
     "0641-6056-10",
     "0641-6061-01",
     "0641-6061-10",
     "0641-6061-25",
     "0641-6063-01",
     "0641-6063-10",
     "0641-6063-25",
     "0641-6060-01",
     "0641-6060-10"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "63323-412-25",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Unavailable",
   "related_info": "Next release September 2026. Check wholesalers for inventory.",
   "openfda": {
    "application_number": [
     "ANDA075154"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-412",
     "63323-411"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "311700",
     "311702"
    ],
    "spl_id": [
     "9814447b-a93e-42ad-b57e-5db0a5b7f552"
    ],
    "spl_set_id": [
     "a91ce254-14a3-4cbf-8ab8-5da252aa3fdc"
    ],
    "package_ndc": [
     "63323-411-22",
     "63323-411-27",
     "63323-411-15",
     "63323-411-12",
     "63323-411-18",
     "63323-411-25",
     "63323-411-13",
     "63323-411-10",
     "63323-412-18",
     "63323-412-25",
     "63323-412-03",
     "63323-412-02",
     "63323-412-06",
     "63323-412-05",
     "63323-412-13",
     "63323-412-10"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-25)",
   "company_name": "Fresenius Kabi USA, LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "44567-610-10",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "888-493-0861",
   "availability": "Available",
   "related_info": "Please check wholesalers and distributors for inventory.",
   "openfda": {
    "application_number": [
     "NDA211844"
    ],
    "brand_name": [
     "MIDAZOLAM IN SODIUM CHLORIDE"
    ],
    "generic_name": [
     "MIDAZOLAM"
    ],
    "manufacturer_name": [
     "WG Critical Care, LLC."
    ],
    "product_ndc": [
     "44567-610",
     "44567-611"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM"
    ],
    "rxcui": [
     "2541170",
     "2541171"
    ],
    "spl_id": [
     "6cea9d5b-d0a6-4f93-b45e-2d615f6c4337"
    ],
    "spl_set_id": [
     "f051776f-94c5-4e34-80ed-f45b9c36881e"
    ],
    "package_ndc": [
     "44567-610-01",
     "44567-610-10",
     "44567-611-01",
     "44567-611-10"
    ],
    "nui": [
     "N0000175694",
     "M0002356"
    ],
    "pharm_class_epc": [
     "Benzodiazepine [EPC]"
    ],
    "pharm_class_cs": [
     "Benzodiazepines [CS]"
    ],
    "unii": [
     "R60L0SM5BC"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10)",
   "company_name": "WG Critical Care",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "0409-2587-05",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA075293"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-2587",
     "0409-2596"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "311700",
     "311702"
    ],
    "spl_id": [
     "6c075a2d-b68b-41a7-aa0c-bcf9894e3f76"
    ],
    "spl_set_id": [
     "affecd4d-1f78-4bbe-5a8d-86849bbdc520"
    ],
    "package_ndc": [
     "0409-2587-04",
     "0409-2587-05",
     "0409-2596-13",
     "0409-2596-03",
     "0409-2596-15",
     "0409-2596-05"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "0641-6059-01",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Additional lots will be available in the September 2026 timeframe.  Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA075243"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6059",
     "0641-6057",
     "0641-6056",
     "0641-6061",
     "0641-6063",
     "0641-6060"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "311700",
     "311702"
    ],
    "spl_id": [
     "559c03fb-24ea-4b7b-8afd-e33cb3a2340a"
    ],
    "spl_set_id": [
     "575d8bf0-7af7-427c-a231-966e2a5e070d"
    ],
    "package_ndc": [
     "0641-6057-01",
     "0641-6057-10",
     "0641-6057-25",
     "0641-6059-01",
     "0641-6059-10",
     "0641-6056-01",
     "0641-6056-10",
     "0641-6061-01",
     "0641-6061-10",
     "0641-6061-25",
     "0641-6063-01",
     "0641-6063-10",
     "0641-6063-25",
     "0641-6060-01",
     "0641-6060-10"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "63323-411-12",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Unavailable",
   "related_info": "Next release August 2026. Check wholesalers for inventory.",
   "openfda": {
    "application_number": [
     "ANDA075154"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-411",
     "63323-412"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "311700",
     "311702"
    ],
    "spl_id": [
     "9814447b-a93e-42ad-b57e-5db0a5b7f552"
    ],
    "spl_set_id": [
     "a91ce254-14a3-4cbf-8ab8-5da252aa3fdc"
    ],
    "package_ndc": [
     "63323-411-22",
     "63323-411-27",
     "63323-411-15",
     "63323-411-12",
     "63323-411-18",
     "63323-411-25",
     "63323-411-13",
     "63323-411-10",
     "63323-412-18",
     "63323-412-25",
     "63323-412-03",
     "63323-412-02",
     "63323-412-06",
     "63323-412-05",
     "63323-412-13",
     "63323-412-10"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12)",
   "company_name": "Fresenius Kabi USA, LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "0409-2308-02",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA075857"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-2308",
     "0409-2305",
     "0409-0001"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "1666800",
     "1666814",
     "1666823",
     "1666798"
    ],
    "spl_id": [
     "2f69c5b1-6505-42dc-8bb3-edbd9b6c0781",
     "8954486a-8512-4831-8178-0b49f1efb73e"
    ],
    "spl_set_id": [
     "b95415fa-17c2-42ab-a6b0-e628d01c94ed",
     "1abda8b8-48a8-4995-af86-39220d1aa240"
    ],
    "package_ndc": [
     "0409-2305-55",
     "0409-2305-50",
     "0409-2308-69",
     "0409-2308-49",
     "0409-2308-70",
     "0409-2308-50",
     "0409-2305-16",
     "0409-2305-17",
     "0409-2305-04",
     "0409-2305-05",
     "0409-2308-21",
     "0409-2308-01",
     "0409-2308-22",
     "0409-2308-02",
     "0409-0001-01",
     "0409-0001-25"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "0409-2596-05",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA075293"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-2596",
     "0409-2587"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "311700",
     "311702"
    ],
    "spl_id": [
     "6c075a2d-b68b-41a7-aa0c-bcf9894e3f76"
    ],
    "spl_set_id": [
     "affecd4d-1f78-4bbe-5a8d-86849bbdc520"
    ],
    "package_ndc": [
     "0409-2587-04",
     "0409-2587-05",
     "0409-2596-13",
     "0409-2596-03",
     "0409-2596-15",
     "0409-2596-05"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "63323-412-10",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA075154"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-412",
     "63323-411"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "311700",
     "311702"
    ],
    "spl_id": [
     "9814447b-a93e-42ad-b57e-5db0a5b7f552"
    ],
    "spl_set_id": [
     "a91ce254-14a3-4cbf-8ab8-5da252aa3fdc"
    ],
    "package_ndc": [
     "63323-411-22",
     "63323-411-27",
     "63323-411-15",
     "63323-411-12",
     "63323-411-18",
     "63323-411-25",
     "63323-411-13",
     "63323-411-10",
     "63323-412-18",
     "63323-412-25",
     "63323-412-03",
     "63323-412-02",
     "63323-412-06",
     "63323-412-05",
     "63323-412-13",
     "63323-412-10"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-10)",
   "company_name": "Fresenius Kabi USA, LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "25021-655-02",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "Avet Pharmaceuticals, Inc.: 855-228-9470; Sagent Pharmaceuticals: 866-625-1618",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals",
   "openfda": {
    "application_number": [
     "ANDA090696"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Sagent Pharmaceuticals"
    ],
    "product_ndc": [
     "25021-655"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "1666798"
    ],
    "spl_id": [
     "943346c0-d98e-4ac2-a1a2-75427decf2fc"
    ],
    "spl_set_id": [
     "e22611dd-1830-40af-9139-7cdb07f5a426"
    ],
    "package_ndc": [
     "25021-655-02"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "07/22/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 25021-655-02)",
   "company_name": "Gland Pharma Limited",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "23155-601-41",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "855-228-9470",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA090850"
    ],
    "brand_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "generic_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."
    ],
    "product_ndc": [
     "23155-601"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "311702"
    ],
    "spl_id": [
     "e20feff9-3aca-4bc1-a5c3-44fff8a9459c"
    ],
    "spl_set_id": [
     "843cc25e-45ea-4372-ae34-843f805fa869"
    ],
    "package_ndc": [
     "23155-601-31",
     "23155-601-41",
     "23155-601-32",
     "23155-601-42"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-41)",
   "company_name": "Avet Pharmaceuticals, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "0641-6060-10",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional lots are scheduled to be manufactured.  Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA075243"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6060",
     "0641-6057",
     "0641-6059",
     "0641-6056",
     "0641-6061",
     "0641-6063"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "311700",
     "311702"
    ],
    "spl_id": [
     "559c03fb-24ea-4b7b-8afd-e33cb3a2340a"
    ],
    "spl_set_id": [
     "575d8bf0-7af7-427c-a231-966e2a5e070d"
    ],
    "package_ndc": [
     "0641-6057-01",
     "0641-6057-10",
     "0641-6057-25",
     "0641-6059-01",
     "0641-6059-10",
     "0641-6056-01",
     "0641-6056-10",
     "0641-6061-01",
     "0641-6061-10",
     "0641-6061-25",
     "0641-6063-01",
     "0641-6063-10",
     "0641-6063-25",
     "0641-6060-01",
     "0641-6060-10"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "0641-6057-25",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA075243"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6057",
     "0641-6059",
     "0641-6056",
     "0641-6061",
     "0641-6063",
     "0641-6060"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "311700",
     "311702"
    ],
    "spl_id": [
     "559c03fb-24ea-4b7b-8afd-e33cb3a2340a"
    ],
    "spl_set_id": [
     "575d8bf0-7af7-427c-a231-966e2a5e070d"
    ],
    "package_ndc": [
     "0641-6057-01",
     "0641-6057-10",
     "0641-6057-25",
     "0641-6059-01",
     "0641-6059-10",
     "0641-6056-01",
     "0641-6056-10",
     "0641-6061-01",
     "0641-6061-10",
     "0641-6061-25",
     "0641-6063-01",
     "0641-6063-10",
     "0641-6063-25",
     "0641-6060-01",
     "0641-6060-10"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "0641-6061-25",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional lots are scheduled to be manufactured.  Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA075243"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6061",
     "0641-6057",
     "0641-6059",
     "0641-6056",
     "0641-6063",
     "0641-6060"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "311700",
     "311702"
    ],
    "spl_id": [
     "559c03fb-24ea-4b7b-8afd-e33cb3a2340a"
    ],
    "spl_set_id": [
     "575d8bf0-7af7-427c-a231-966e2a5e070d"
    ],
    "package_ndc": [
     "0641-6057-01",
     "0641-6057-10",
     "0641-6057-25",
     "0641-6059-01",
     "0641-6059-10",
     "0641-6056-01",
     "0641-6056-10",
     "0641-6061-01",
     "0641-6061-10",
     "0641-6061-25",
     "0641-6063-01",
     "0641-6063-10",
     "0641-6063-25",
     "0641-6060-01",
     "0641-6060-10"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6061-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "25021-661-10",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "Avet Pharmaceuticals, Inc.: 855-228-9470; Sagent Pharmaceuticals: 866-625-1618",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals",
   "openfda": {
    "application_number": [
     "ANDA090850"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Sagent Pharmaceuticals"
    ],
    "product_ndc": [
     "25021-661"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "311702"
    ],
    "spl_id": [
     "002ea282-09ba-4d79-8bd1-94c9859f442b"
    ],
    "spl_set_id": [
     "880cac48-5c0f-49a9-8aef-3c9770bf5d84"
    ],
    "package_ndc": [
     "25021-661-10"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "07/22/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-661-10)",
   "company_name": "Gland Pharma Limited",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "0409-2305-05",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Limited Availability",
   "related_info": "Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026",
   "openfda": {
    "application_number": [
     "ANDA075857"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-2305",
     "0409-2308",
     "0409-0001"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "1666800",
     "1666814",
     "1666823",
     "1666798"
    ],
    "spl_id": [
     "2f69c5b1-6505-42dc-8bb3-edbd9b6c0781",
     "8954486a-8512-4831-8178-0b49f1efb73e"
    ],
    "spl_set_id": [
     "b95415fa-17c2-42ab-a6b0-e628d01c94ed",
     "1abda8b8-48a8-4995-af86-39220d1aa240"
    ],
    "package_ndc": [
     "0409-2305-55",
     "0409-2305-50",
     "0409-2308-69",
     "0409-2308-49",
     "0409-2308-70",
     "0409-2308-50",
     "0409-2305-16",
     "0409-2305-17",
     "0409-2305-04",
     "0409-2305-05",
     "0409-2308-21",
     "0409-2308-01",
     "0409-2308-22",
     "0409-2308-02",
     "0409-0001-01",
     "0409-0001-25"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "0409-2305-17",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA075857"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-2305",
     "0409-2308",
     "0409-0001"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "1666800",
     "1666814",
     "1666823",
     "1666798"
    ],
    "spl_id": [
     "2f69c5b1-6505-42dc-8bb3-edbd9b6c0781",
     "8954486a-8512-4831-8178-0b49f1efb73e"
    ],
    "spl_set_id": [
     "b95415fa-17c2-42ab-a6b0-e628d01c94ed",
     "1abda8b8-48a8-4995-af86-39220d1aa240"
    ],
    "package_ndc": [
     "0409-2305-55",
     "0409-2305-50",
     "0409-2308-69",
     "0409-2308-49",
     "0409-2308-70",
     "0409-2308-50",
     "0409-2305-16",
     "0409-2305-17",
     "0409-2305-04",
     "0409-2305-05",
     "0409-2308-21",
     "0409-2308-01",
     "0409-2308-22",
     "0409-2308-02",
     "0409-0001-01",
     "0409-0001-25"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "63323-411-10",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA075154"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-411",
     "63323-412"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "311700",
     "311702"
    ],
    "spl_id": [
     "9814447b-a93e-42ad-b57e-5db0a5b7f552"
    ],
    "spl_set_id": [
     "a91ce254-14a3-4cbf-8ab8-5da252aa3fdc"
    ],
    "package_ndc": [
     "63323-411-22",
     "63323-411-27",
     "63323-411-15",
     "63323-411-12",
     "63323-411-18",
     "63323-411-25",
     "63323-411-13",
     "63323-411-10",
     "63323-412-18",
     "63323-412-25",
     "63323-412-03",
     "63323-412-02",
     "63323-412-06",
     "63323-412-05",
     "63323-412-13",
     "63323-412-10"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10)",
   "company_name": "Fresenius Kabi USA, LLC",
   "shortage_reason": "Delay in shipping of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "23155-601-42",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "855-228-9470",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA090850"
    ],
    "brand_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "generic_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."
    ],
    "product_ndc": [
     "23155-601"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "311702"
    ],
    "spl_id": [
     "e20feff9-3aca-4bc1-a5c3-44fff8a9459c"
    ],
    "spl_set_id": [
     "843cc25e-45ea-4372-ae34-843f805fa869"
    ],
    "package_ndc": [
     "23155-601-31",
     "23155-601-41",
     "23155-601-32",
     "23155-601-42"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-42)",
   "company_name": "Avet Pharmaceuticals, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "04/02/2020",
   "package_ndc": "0409-2308-01",
   "generic_name": "Midazolam Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Next Delivery: September 2026; Estimated Recovery: December 2026",
   "openfda": {
    "application_number": [
     "ANDA075857"
    ],
    "brand_name": [
     "MIDAZOLAM"
    ],
    "generic_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-2308",
     "0409-2305",
     "0409-0001"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MIDAZOLAM HYDROCHLORIDE"
    ],
    "rxcui": [
     "1666800",
     "1666814",
     "1666823",
     "1666798"
    ],
    "spl_id": [
     "2f69c5b1-6505-42dc-8bb3-edbd9b6c0781",
     "8954486a-8512-4831-8178-0b49f1efb73e"
    ],
    "spl_set_id": [
     "b95415fa-17c2-42ab-a6b0-e628d01c94ed",
     "1abda8b8-48a8-4995-af86-39220d1aa240"
    ],
    "package_ndc": [
     "0409-2305-55",
     "0409-2305-50",
     "0409-2308-69",
     "0409-2308-49",
     "0409-2308-70",
     "0409-2308-50",
     "0409-2305-16",
     "0409-2305-17",
     "0409-2305-04",
     "0409-2305-05",
     "0409-2308-21",
     "0409-2308-01",
     "0409-2308-22",
     "0409-2308-02",
     "0409-0001-01",
     "0409-0001-25"
    ],
    "unii": [
     "W7TTW573JJ"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  }
 ]
}